vs
Side-by-side financial comparison of ARGENX SE (ARGX) and QVC INC (QVCD). Click either name above to swap in a different company.
ARGENX SE is the larger business by last-quarter revenue ($2.5B vs $2.4B, roughly 1.0× QVC INC). ARGENX SE runs the higher net margin — 35.5% vs 1.5%, a 33.9% gap on every dollar of revenue. On growth, ARGENX SE posted the faster year-over-year revenue change (83.2% vs -8.9%).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
QVC Group, is an American media conglomerate controlled by company chairman John C. Malone, who owns a majority of the voting shares.
ARGX vs QVCD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.5B | $2.4B |
| Net Profit | $877.2M | $37.0M |
| Gross Margin | 89.5% | 32.5% |
| Operating Margin | 28.9% | 5.6% |
| Net Margin | 35.5% | 1.5% |
| Revenue YoY | 83.2% | -8.9% |
| Net Profit YoY | 1.3% | 103.0% |
| EPS (diluted) | $13.25 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.5B | $2.4B | ||
| Q3 25 | — | $2.0B | ||
| Q2 25 | $1.8B | $2.0B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | $1.4B | $2.7B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | $901.9M | $2.1B | ||
| Q1 24 | — | $2.1B |
| Q4 25 | $877.2M | $37.0M | ||
| Q3 25 | — | $2.0M | ||
| Q2 25 | $414.8M | $-2.2B | ||
| Q1 25 | — | $-42.0M | ||
| Q4 24 | $865.6M | $-1.2B | ||
| Q3 24 | — | $51.0M | ||
| Q2 24 | $-32.5M | $53.0M | ||
| Q1 24 | — | $51.0M |
| Q4 25 | 89.5% | 32.5% | ||
| Q3 25 | — | 33.6% | ||
| Q2 25 | 89.2% | 35.4% | ||
| Q1 25 | — | 33.3% | ||
| Q4 24 | 90.2% | 32.6% | ||
| Q3 24 | — | 34.7% | ||
| Q2 24 | 89.4% | 35.6% | ||
| Q1 24 | — | 35.0% |
| Q4 25 | 28.9% | 5.6% | ||
| Q3 25 | — | 4.6% | ||
| Q2 25 | 19.2% | -114.5% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | 8.7% | -47.1% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | -15.4% | 7.6% | ||
| Q1 24 | — | 7.4% |
| Q4 25 | 35.5% | 1.5% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | 23.4% | -109.1% | ||
| Q1 25 | — | -2.2% | ||
| Q4 24 | 64.1% | -46.0% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | -3.6% | 2.5% | ||
| Q1 24 | — | 2.4% |
| Q4 25 | $13.25 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $6.32 | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $13.33 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-0.55 | — | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.5B | $1.5B |
| Total DebtLower is stronger | — | $1.0M |
| Stockholders' EquityBook value | $7.3B | $1.2B |
| Total Assets | $8.7B | $8.5B |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.5B | $1.5B | ||
| Q3 25 | — | — | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.5B | $297.0M | ||
| Q3 24 | — | $297.0M | ||
| Q2 24 | $1.4B | $315.0M | ||
| Q1 24 | — | $311.0M |
| Q4 25 | — | $1.0M | ||
| Q3 25 | — | $5.0B | ||
| Q2 25 | — | $4.0B | ||
| Q1 25 | — | $4.0B | ||
| Q4 24 | — | $3.3B | ||
| Q3 24 | — | $3.4B | ||
| Q2 24 | $11.0M | $3.7B | ||
| Q1 24 | — | $3.8B |
| Q4 25 | $7.3B | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | $6.1B | $1.2B | ||
| Q1 25 | — | $3.3B | ||
| Q4 24 | $5.5B | $3.3B | ||
| Q3 24 | — | $4.6B | ||
| Q2 24 | $4.3B | $4.3B | ||
| Q1 24 | — | $4.2B |
| Q4 25 | $8.7B | $8.5B | ||
| Q3 25 | — | $8.3B | ||
| Q2 25 | $7.2B | $7.4B | ||
| Q1 25 | — | $9.7B | ||
| Q4 24 | $6.2B | $9.9B | ||
| Q3 24 | — | $9.9B | ||
| Q2 24 | $4.8B | $11.2B | ||
| Q1 24 | — | $11.4B |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 4.30× | ||
| Q2 25 | — | 3.42× | ||
| Q1 25 | — | 1.22× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 0.73× | ||
| Q2 24 | 0.00× | 0.87× | ||
| Q1 24 | — | 0.89× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $323.3M | $245.0M |
| Free Cash FlowOCF − Capex | $322.4M | — |
| FCF MarginFCF / Revenue | 13.0% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | 0.37× | 6.62× |
| TTM Free Cash FlowTrailing 4 quarters | $594.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $323.3M | $245.0M | ||
| Q3 25 | — | $76.0M | ||
| Q2 25 | $361.8M | $52.0M | ||
| Q1 25 | — | $46.0M | ||
| Q4 24 | $41.9M | $189.0M | ||
| Q3 24 | — | $98.0M | ||
| Q2 24 | $-124.7M | $164.0M | ||
| Q1 24 | — | $84.0M |
| Q4 25 | $322.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $356.6M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $40.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-125.5M | — | ||
| Q1 24 | — | — |
| Q4 25 | 13.0% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 20.1% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -13.9% | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.37× | 6.62× | ||
| Q3 25 | — | 38.00× | ||
| Q2 25 | 0.87× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | — | 1.92× | ||
| Q2 24 | — | 3.09× | ||
| Q1 24 | — | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ARGX
Segment breakdown not available.
QVCD
| Home | $754.0M | 31% |
| QVC International | $661.0M | 27% |
| Beauty | $260.0M | 11% |
| Apparel | $254.0M | 10% |
| Electronics | $187.0M | 8% |
| Accessories | $181.0M | 7% |
| Jewelry | $87.0M | 4% |
| Otherrevenue | $38.0M | 2% |
